ContraFect upgraded by WBB Securities with a new price target
$CFRX
Biotechnology: Pharmaceutical Preparations
Health Care
WBB Securities upgraded ContraFect from Speculative Buy to Buy and set a new price target of $6.50
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/14/2022 | $1.00 | Outperform → Mkt Perform | SVB Leerink |
| 7/14/2022 | $15.00 → $1.00 | Overweight → Neutral | Cantor Fitzgerald |
| 2/16/2022 | $14.00 → $9.00 | Outperform | SVB Leerink |
| 2/2/2022 | $6.50 | Speculative Buy → Buy | WBB Securities |
| 9/9/2021 | $14.00 | Outperform | SVB Leerink |